betaxolol and propranolol

betaxolol has been researched along with propranolol in 76 studies

Research

Studies (76)

TimeframeStudies, this research(%)All Research%
pre-199032 (42.11)18.7374
1990's20 (26.32)18.2507
2000's12 (15.79)29.6817
2010's10 (13.16)24.3611
2020's2 (2.63)2.80

Authors

AuthorsStudies
Baldwin, JJ; Christy, ME; Denny, GH; Freedman, MB; Gross, DM; Habecker, CN; Lyle, PA; Ponticello, GS; Sweet, CS; Varga, SL1
Binet, JL; Cavero, IG; Lefèvre-Borg, F; Manoury, PM; Rousseau, J1
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H1
Baldwin, JJ; Denny, GH; Freedman, MB; Gross, DM; Hirschmann, R; Ponticello, GS; Sweet, CS1
Iakovidis, D; Jackman, GP; Louis, SN; Louis, WJ; Nero, TL1
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY1
Chandrasena, G; Gavai, AV; Nayeem, A; Santone, K; Vaz, RJ1
Abraham, MH; Acree, WE; Ibrahim, A1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Catteau, J; Dumon, JP; Dupuis, BA; Lanvin, F1
Gayet, J; Ginefri-Gayet, M1
Jackson, HC; Nutt, DJ1
Beckwith, LJ; Benn, JJ; Brown, PM; Farebrother, M; Sönksen, PH1
Adler, LA; Angrist, B; Rotrosen, J1
Bessho, H; Kitada, Y; Narimatsu, A; Suzuki, J; Tobe, A1
Irvine, NA; Lipworth, BJ; McDevitt, DG1
Bessho, H; Kitada, Y; Narimatsu, A; Satoh, N; Suzuki, J; Tobe, A1
Narahara, KA1
Abe, Y; Narimatsu, A; Tobe, A1
Belz, GG; Palm, D; Wellstein, A1
Edwards, DJ; Knopf, S; Sorisio, DA1
Brizendine, M; Hazen, JF; Mena, I; Narahara, KA; Thompson, CJ1
Akritopoulos, P; Petounis, AD1
Barnes, PJ; Meldrum, LA; Rhoden, KJ1
Birmingham, AT; Patrick, JM; Wharrad, HJ; Wilson, CG1
Riddell, JG; Shanks, RG1
Brunswick, DJ; Church, AC; Flexner, JB; Flexner, LB; Rainbow, TC1
Canal, M; Carbon, C; Cascio, B; Domart, Y; Flouvat, B; Larribaud, J; Orofiamma, B; Roux, A; Vinceneux, P1
Bevan, JA; McPherson, GA1
Catteau, J; Dumon, JP; Dupuis, B; Libert, C; Petit, H1
Cavero, I; Hicks, PE; Langer, SZ; Lefevre-Borg, F; Manoury, P1
Christoforov, B; d'Athis, P; de Lauture, D; Jammet, P; Olive, G; Rey, E; Weber, S1
Dorow, P1
Cangiano, J; Davidov, ME; Glazer, N; Wollam, G; Zager, PG1
Braillon, A; Geoffroy, P; Lebrec, D; Lee, SS; Sauvanet, JP; Valla, D1
Bojanic, D; Jansen, JD; Nahorski, SR; Zaagsma, J1
Brunswick, DJ; Conway, PG; Tondo, L1
Arlot, S; Lalau, JD; Lourdel, C; Quichaud, J; Sauvanet, JP1
Bianchetti, G; Brancaccio, D; Forette, F; Ganansia, J; Gomeni, R; Henry, JF; Hervy, MP; Kilborn, JR; Morselli, PL1
Bianchetti, G; Chauvin, M; Giudicelli, JF; Gomeni, R; Morselli, PL; Richer, C; Thuillez, C1
Gomeni, R; Kilborn, JR; Morselli, PL; Saunders, J; Sönksen, PH1
Avery, AJ; Kilborn, JR; Morselli, PL; Prestwich, SA; Saunders, J; Sönksen, PH1
Anlauf, M; Bock, KD; Brodde, OE; Weber, F1
Kaik, G; Palminteri, R1
Biamino, G; Schröder, R1
Curtis-Prior, PB; Tan, S1
Battin, J; Colle, M; Coquelin, JP; Rochiccioli, P1
Hartogensis, WE; Long, CS; Simpson, PC1
Frith, S; O'Donnell, JM; Wilkins, J1
Enjaume, C; Oliver, I; Pienkowski, C; Rochiccioli, P; Tauber, MT1
Ayaori, M; Hosoai, H; Ishikawa, T; Nakamura, H; Nishio, E; Shige, H; Suzukawa, M; Yoshida, H1
Manavalan, JS; Quartermain, D; Stone, EA1
Kitada, Y1
Kleven, MS; Koek, W1
Hoste, AM; Sys, SU1
Melena, J; Osborne, NN; Wood, JP1
Aston-Jones, G; Delfs, JM; Druhan, JP; Zhu, Y1
Chidlow, G; Melena, J; Osborne, NN1
Jazvinscak, M; Mirkovic, K; Pericic, D; Svob, D1
Antunes, E; Arantes, EC; Baracat, JS; De Nucci, G; Teixeira, CE1
Maestroni, GJ; Manni, M1
Chantasart, D; Hao, J; Li, SK1
Al-Hasani, R; Bruchas, MR; Foshage, AM; McCall, JG1
Huang, B; Liu, X; Ma, L; Zhou, Y; Zhu, H1
Dany, M1
Alam, SD; Ali, I; Aljuwayid, AM; Jain, AK; Raja, R; Shirsath, V; Sillanpää, M; Yusuf, K1
De Oliveira Sergio, T; Hopf, FW; Katner, SN; Wean, S1

Reviews

5 review(s) available for betaxolol and propranolol

ArticleYear
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship

1988
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
What is the real pharmacological rationale for beta-receptor blocking agents?
    European heart journal, 1983, Volume: 4 Suppl D

    Topics: Adrenergic beta-Antagonists; Betaxolol; Coronary Disease; Heart Rate; Humans; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption; Penbutolol; Physical Exertion; Propanolamines; Propranolol

1983
Beta-Blockers for Pyogenic Granuloma: A Systematic Review of Case Reports, Case Series, and Clinical Trials
    Journal of drugs in dermatology : JDD, 2019, 10-01, Volume: 18, Issue:10

    Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Betaxolol; Clinical Trials as Topic; Granuloma, Pyogenic; Humans; Propranolol; Receptors, Adrenergic, beta; Recurrence; Skin; Skin Diseases; Timolol; Treatment Outcome

2019
Chiral separation of β-blockers by supercritical fluid chromatography using Chiralpak-IG and Chiralpak IBN-5 columns.
    Chirality, 2022, Volume: 34, Issue:6

    Topics: Adrenergic beta-Antagonists; Atenolol; Betaxolol; Chromatography, Supercritical Fluid; Propranolol; Stereoisomerism

2022

Trials

14 trial(s) available for betaxolol and propranolol

ArticleYear
Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia.
    The American journal of psychiatry, 1992, Volume: 149, Issue:5

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Betaxolol; Double-Blind Method; Humans; Middle Aged; Placebos; Propranolol; Psychomotor Agitation

1992
A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.
    British journal of clinical pharmacology, 1990, Volume: 30, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Leg; Male; Propranolol; Receptors, Adrenergic, beta; Regional Blood Flow; Tremor

1990
Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group.
    The American journal of cardiology, 1990, Mar-01, Volume: 65, Issue:9

    Topics: Angina Pectoris; Betaxolol; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propranolol; Randomized Controlled Trials as Topic

1990
The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease.
    American heart journal, 1989, Volume: 117, Issue:5

    Topics: Adrenergic beta-Agonists; Algorithms; Betaxolol; Blood Pressure; Coronary Disease; Exercise; Female; Heart Rate; Humans; Male; Propanolamines; Propranolol; Thallium Radioisotopes; Tomography, Emission-Computed

1989
The effect of a week's beta-adrenoceptor antagonism on daytime heart-rates, subjective responses to exercise, and physical activity in normal subjects.
    British journal of clinical pharmacology, 1985, Volume: 19, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Time Factors

1985
Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Blood Pressure; Heart Rate; Humans; Isoproterenol; Male; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vascular Resistance

1985
Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Pressure; Drug Interactions; Exercise Test; Heart Rate; Humans; Kinetics; Male; Nifedipine; Propanolamines; Propranolol

1986
Comparison of propranolol, sotalol, and betaxolol in the treatment of neuroleptic-induced akathisia.
    The American journal of psychiatry, 1987, Volume: 144, Issue:6

    Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Betaxolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol; Psychomotor Agitation; Sotalol

1987
[Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Arzneimittel-Forschung, 1987, Volume: 37, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Lung Diseases, Obstructive; Male; Middle Aged; Propanolamines; Propranolol; Respiration

1987
Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    American journal of hypertension, 1988, Volume: 1, Issue:3 Pt 3

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propanolamines; Propranolol

1988
Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis.
    Scandinavian journal of gastroenterology, 1988, Volume: 23, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Female; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Propanolamines; Propranolol; Splanchnic Circulation

1988
Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Betaxolol; Female; Humans; Male; Propanolamines; Propranolol; Uremia

1980
Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    British journal of clinical pharmacology, 1980, Volume: 10, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Pressure; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Kinetics; Male; Myocardial Contraction; Peak Expiratory Flow Rate; Propanolamines; Propranolol; Renin

1980
Betaxolol and propranolol in glucagon stimulation of growth hormone.
    Archives of disease in childhood, 1984, Volume: 59, Issue:7

    Topics: Adolescent; Adrenergic beta-Antagonists; Betaxolol; Child; Child, Preschool; Female; Glucagon; Growth Disorders; Growth Hormone; Humans; Infant; Male; Propanolamines; Propranolol; Stimulation, Chemical

1984

Other Studies

57 other study(ies) available for betaxolol and propranolol

ArticleYear
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Female; Guinea Pigs; Heart Rate; Hydrogen Bonding; Imidazoles; In Vitro Techniques; Receptors, Adrenergic, beta; Solubility; Structure-Activity Relationship

1986
Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:6

    Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Antihypertensive Agents; Betaxolol; Biotransformation; Cardiovascular Diseases; Chronic Disease; Female; Guinea Pigs; In Vitro Techniques; Kinetics; Male; Propanolamines; Rana esculenta; Rats; Structure-Activity Relationship

1987
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class.
    Journal of medicinal chemistry, 1983, Volume: 26, Issue:7

    Topics: Adrenergic alpha-Agonists; Animals; Female; Guinea Pigs; Heart; Imidazoles; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Receptors, Adrenergic; Receptors, Adrenergic, beta; Structure-Activity Relationship

1983
LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.
    European journal of pharmacology, 1999, Feb-19, Volume: 367, Issue:2-3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; Cyclopropanes; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Phenoxypropanolamines; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea; Urea

1999
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.
    Bioorganic & medicinal chemistry letters, 2005, Sep-01, Volume: 15, Issue:17

    Topics: Animals; Cytochrome P-450 CYP2D6 Inhibitors; Humans; Inhibitory Concentration 50; Models, Molecular; Propanolamines; Quantitative Structure-Activity Relationship; Substrate Specificity

2005
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Involvement of serotonin receptors in methionine sulfoximine-induced hypothermia in the rat.
    European journal of pharmacology, 1992, Jun-24, Volume: 217, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Body Temperature; Central Nervous System; Dose-Response Relationship, Drug; Hypothermia, Induced; Ketanserin; Male; Methionine Sulfoximine; Pindolol; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Serotonin

1992
Are 5-HT receptors or beta-adrenoceptors involved in idazoxan-induced food and water intake?
    Neuropharmacology, 1992, Volume: 31, Issue:11

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Dioxanes; Dose-Response Relationship, Drug; Drinking; Eating; Idazoxan; Male; Metergoline; Propanolamines; Propranolol; Quinolizines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Serotonin; Stereoisomerism

1992
Glucose turnover in type I diabetic subjects during exercise. Effect of selective and nonselective beta-blockade and insulin withdrawal.
    Diabetes care, 1992, Volume: 15, Issue:11

    Topics: Adult; Atenolol; Betaxolol; Blood Glucose; Diabetes Mellitus, Type 1; Exercise; Glucose; Glycated Hemoglobin; Humans; Insulin; Kinetics; Male; Physical Exertion; Propranolol; Tritium

1992
Efficacy of betaxolol in neuroleptic-induced akathisia.
    Psychiatry research, 1991, Volume: 39, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Betaxolol; Drug Administration Schedule; Humans; Middle Aged; Neurologic Examination; Propranolol; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology

1991
[Antihypertensive effect of betaxolol, a cardioselective beta-adrenoceptor antagonist, in renal hypertensive dogs].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1990, Volume: 95, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension, Renal; Male; Propranolol

1990
Effects of betaxolol on cardiohemodynamics and coronary circulation in anesthetized dogs: comparison with atenolol and propranolol.
    Japanese journal of pharmacology, 1990, Volume: 54, Issue:2

    Topics: Animals; Atenolol; Betaxolol; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Female; Heart; Heart Rate; Hemodynamics; Male; Propranolol

1990
Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:2

    Topics: Acidosis; Animals; Atenolol; Betaxolol; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Female; Heart Rate; Hydrogen-Ion Concentration; Male; Propranolol

1990
Affinity and selectivity of beta-adrenoceptor antagonists in vitro.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 11

    Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding, Competitive; Bisoprolol; Propanolamines; Propranolol; Rats; Salivary Glands; Tritium

1986
Effects of the beta 2-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat.
    Biochemical pharmacology, 1989, Sep-15, Volume: 38, Issue:18

    Topics: Amino Acids; Animals; Betaxolol; Brain Chemistry; Clenbuterol; Dose-Response Relationship, Drug; Ethanolamines; Male; Methysergide; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Tryptophan; Tyrosine

1989
Influence of topical and systemic beta-blockers on tear production.
    International ophthalmology, 1989, Volume: 13, Issue:1-2

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Butoxamine; Drug Administration Routes; Injections, Intramuscular; Lacrimal Apparatus; Male; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Rabbits; Time Factors; Timolol

1989
Inhibition of cholinergic neurotransmission in human airways by beta 2-adrenoceptors.
    Journal of applied physiology (Bethesda, Md. : 1985), 1988, Volume: 65, Issue:2

    Topics: Acetylcholine; Adult; Aged; Betaxolol; Bronchi; Catecholamines; Electric Stimulation; Epinephrine; Humans; Isoproterenol; Middle Aged; Muscle Contraction; Muscle, Smooth; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Synaptic Transmission

1988
Blockade of beta 1- but not of beta 2-adrenergic receptors replicates propranolol's suppression of the cerebral spread of an engram in mice.
    Proceedings of the National Academy of Sciences of the United States of America, 1985, Volume: 82, Issue:21

    Topics: Adrenergic beta-Antagonists; Amnesia; Animals; Avoidance Learning; Betaxolol; Brain; Cerebellum; Hippocampus; Memory; Mice; Propanolamines; Propranolol; Puromycin; Receptors, Adrenergic, beta; Time Factors

1985
Specialization in beta-1 and beta-2 adrenoceptor distribution in veins of the rabbit face: relationship to myogenic tone and sympathetic nerve innervation.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Catechols; Electrophysiology; Face; Isoproterenol; Male; Metoprolol; Propanolamines; Propranolol; Rabbits; Receptors, Adrenergic, beta; Sympathetic Nervous System; Tetrodotoxin; Veins

1987
Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 242, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Pindolol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta; Trachea; Xamoterol

1987
Effect of cimetidine on the pharmacokinetics of the new beta-blocker betaxolol.
    Arzneimittel-Forschung, 1987, Volume: 37, Issue:8

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Cimetidine; Drug Interactions; Humans; Male; Propanolamines; Propranolol

1987
Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.
    British journal of pharmacology, 1985, Volume: 84, Issue:1

    Topics: Adipose Tissue; Animals; Betaxolol; Cyclic AMP; Epididymis; Fenoterol; Isoproterenol; Lipolysis; Male; Norepinephrine; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta

1985
Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindolol.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 235, Issue:1

    Topics: Alprenolol; Animals; Betaxolol; Binding, Competitive; Brain Stem; Central Nervous System; Cerebellum; Cerebral Cortex; Clenbuterol; Isotope Labeling; Male; Mathematics; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Spinal Cord; Tissue Distribution

1985
GH secretion in patients with hyperthyroidism. Comparison of the effects of long-acting propranolol and betaxolol.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1988, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Betaxolol; Female; Growth Hormone; Humans; Hyperthyroidism; Male; Middle Aged; Propanolamines; Propranolol

1988
A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.
    European journal of clinical pharmacology, 1981, Volume: 21, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Glucose; Blood Pressure; Fatty Acids, Nonesterified; Glycerol; Growth Hormone; Heart Rate; Humans; Hypoglycemia; Insulin; Male; Practolol; Propanolamines; Propranolol

1981
The effect of non-selective and selective beta-1-blockade on the plasma potassium response to hypoglycaemia.
    Diabete & metabolisme, 1981, Volume: 7, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Humans; Hypoglycemia; Insulin; Kinetics; Male; Potassium; Propanolamines; Propranolol; Sodium Chloride

1981
Subclassification of human beta-adrenergic receptors mediating renin release.
    Clinical and experimental hypertension. Part A, Theory and practice, 1983, Volume: 5, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Betaxolol; Dobutamine; Fenoterol; Humans; In Vitro Techniques; Isoproterenol; Male; Metoprolol; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin

1983
Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol.
    European journal of clinical pharmacology, 1983, Volume: 24, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Albuterol; Betaxolol; Blood Pressure; Bronchi; Double-Blind Method; Female; Heart Rate; Humans; Male; Plethysmography, Whole Body; Propanolamines; Propranolol; Time Factors

1983
Characterization of the beta-adrenoceptor of the adipose cell of the rat.
    International journal of obesity, 1983, Volume: 7, Issue:5

    Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Betaxolol; Dose-Response Relationship, Drug; Isoproterenol; Lipolysis; Norepinephrine; Practolol; Prenalterol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta

1983
Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium.
    Journal of molecular and cellular cardiology, 1993, Volume: 25, Issue:8

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Betaxolol; Cardiomegaly; Cell Division; Cells, Cultured; Culture Media, Conditioned; Cyclic AMP; DNA; Growth Substances; Heart; Isoproterenol; Myocardium; Phenylephrine; Propranolol; Rats; Receptors, Adrenergic, beta; RNA, Messenger; Transforming Growth Factor beta

1993
Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:1

    Topics: Animals; Antidepressive Agents; Betaxolol; Clenbuterol; Isoproterenol; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Reinforcement, Psychology

1994
[Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient].
    Annales de pediatrie, 1993, Volume: 40, Issue:7

    Topics: Adolescent; Age Determination by Skeleton; Arginine; Betaxolol; Child; Child, Preschool; Clonidine; Confidence Intervals; Data Interpretation, Statistical; Female; Glucagon; Growth Disorders; Growth Hormone; Humans; Insulin; Levodopa; Male; Normal Distribution; Ornithine; Propranolol; Puberty; Radioimmunoassay; Retrospective Studies; Sensitivity and Specificity

1993
Effects of beta-blockers on HMG CoA reductase and LDL receptor activity in cultured human skin fibroblasts.
    Cardiovascular drugs and therapy, 1996, Volume: 10, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Betaxolol; Cells, Cultured; Fibroblasts; Humans; Hydroxymethylglutaryl CoA Reductases; Lipoproteins, LDL; Male; Metoprolol; Propranolol; Receptors, LDL

1996
Delayed arousal from anesthesia: a further similarity between stress and beta-1 adrenoceptor blockade.
    Pharmacology, biochemistry, and behavior, 1996, Volume: 55, Issue:1

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Anesthesia, General; Anesthetics, Inhalation; Animals; Arousal; Betaxolol; Dose-Response Relationship, Drug; Halothane; Hexobarbital; Hypnotics and Sedatives; Male; Mice; Propanolamines; Propranolol; Sleep; Stress, Psychological; Time Factors

1996
Contrasting effects of betaxolol and propranolol on Ca(2+)-activated contractions in skinned fibers from canine coronary arteries and ventricular muscles.
    Cardiovascular drugs and therapy, 1996, Volume: 10, Issue:5

    Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium; Contractile Proteins; Coronary Vessels; Dogs; Female; Male; Muscle, Smooth, Vascular; Propranolol; Vasoconstriction

1996
Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists.
    Psychopharmacology, 1997, Volume: 131, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Benzofurans; Betaxolol; Brimonidine Tartrate; Cocaine; Discrimination Learning; Discrimination, Psychological; Drug Synergism; Imidazoles; Male; Nadolol; Narcotics; Propanolamines; Propranolol; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Thiophenes

1997
Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium; Calcium Channel Blockers; Cattle; Dinoprost; Endothelium, Vascular; Potassium; Propranolol; Retina; Vasoconstriction; Verapamil

1998
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
    European journal of pharmacology, 1999, Aug-13, Volume: 378, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium

1999
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion.
    Nature, 2000, Jan-27, Volume: 403, Issue:6768

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amygdala; Animals; Betaxolol; Clonidine; Male; Narcotics; Neurons, Afferent; Norepinephrine; Propanolamines; Propranolol; Prosencephalon; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase

2000
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
    British journal of pharmacology, 2000, Volume: 130, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium

2000
Beta-1 adrenoceptor antagonists potentiate the anticonvulsive effect of swim stress in mice.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Betaxolol; Convulsants; Male; Mice; Mice, Inbred CBA; Picrotoxin; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Seizures; Stress, Physiological; Swimming

2000
Effects of beta-adrenoceptor antagonists in the neural nitric oxide release induced by electrical field stimulation and sodium channel activators in the rabbit corpus cavernosum.
    European journal of pharmacology, 2005, Sep-05, Volume: 519, Issue:1-2

    Topics: Aconitine; Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Binding Sites; Electric Stimulation; In Vitro Techniques; Insect Proteins; Male; Metoprolol; Muscle Relaxation; Neurotoxins; Nitric Oxide; Penis; Propanolamines; Propranolol; Rabbits; Saxitoxin; Scorpion Venoms; Sodium Channel Agonists; Tetrodotoxin; Veratridine

2005
Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: involvement of beta-adrenoceptors and relevance in inflammatory diseases.
    Brain, behavior, and immunity, 2008, Volume: 22, Issue:1

    Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Animals; Betaxolol; Cell Movement; Dendritic Cells; Female; Immunity, Innate; Immunization; Immunologic Memory; Inflammation; Injections, Intradermal; Interferon-beta; Ligands; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Peptidoglycan; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Receptors, CXCR3; Skin; Skin Diseases; Sympathetic Nervous System; Th1 Cells

2008
Evaluation of skin permeation of β-blockers for topical drug delivery.
    Pharmaceutical research, 2013, Volume: 30, Issue:3

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Atenolol; Betaxolol; Epidermis; Humans; Middle Aged; Propranolol; Skin; Skin Absorption; Timolol; Young Adult

2013
Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:12

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Clonidine; Cocaine; Conditioning, Psychological; Drug-Seeking Behavior; Locus Coeruleus; Male; Mice; Mice, Inbred C57BL; Naltrexone; Propanolamines; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Opioid, kappa

2013
Unconditioned- and Conditioned- Stimuli Induce Differential Memory Reconsolidation and β-AR-Dependent CREB Activation.
    Frontiers in neural circuits, 2017, Volume: 11

    Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Auditory Perception; Avoidance Learning; Betaxolol; Conditioning, Psychological; Cyclic AMP Response Element-Binding Protein; Electroshock; Fear; Foot; Hippocampus; Male; Memory Consolidation; Memory, Long-Term; Mice, Inbred C57BL; Propanolamines; Propranolol; Receptors, Adrenergic, beta

2017
The role of beta- and alpha-adrenergic receptors on alcohol drinking.
    Neuropharmacology, 2023, 08-15, Volume: 234

    Topics: Alcohol Drinking; Alcoholism; Animals; Betaxolol; Humans; Male; Norepinephrine; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

2023